Clarity Pharmaceuticals Ltd.ASX: CU6

Positive guidance from the US FDA on Cu-64 SARTATE Phase III

Dec 22, 2025 at 3:39 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

The original release is unavailable here.